___

• 1. Yang, J., Lee, J.Y., Na, J.Y., Lim, S.Y., Kim, M.G., Jo, S.K., et al. (2016). Risk factors and outcomes of acute renal infarction. Kidney Res Clin Pract, 35(2): 90–95.
• 2. Covarrubias, N.B., Toledo, M.P., Thomas, M.R., Henderson, I.R., Watson, S.P., Cunningham, A.F. (2019). Understanding infection-induced thrombosis: lessons learned from animal models. Front Immunol, 10: 2569.
• 3. Tang, N., Li, D., Wang, X., Sun, Z. (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost, 18:844–847.
• 4. Eltawansy, S.A., Patel, S., Rao, M., Hassanien, S., Maniar, M. (2014). Acute renal infarction presenting with acute abdominal pain secondary to newly discovered atrial fibrillation: a case report and literature review. Case Rep Emerg Med, 981409.
• 5. Geisbert, T.W., Young, H.A., Jahrling, P.B., Davis, K.J., Kagan, E., Hensley, L.E. (2003). Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis, 188:1618–29.
• 6. Short, K.R., Kroeze, E., Fouchier, R.A.M., Kuiken, T. (2014). Pathogenesis of influenza induced acute respiratory distress syndrome. Lancet Infect Dis, 14:57–69.
• 7. Connors, J.M., Levy, J.H. (2020). COVID-19 and its implications for thrombosis and anticoagulation. Blood, 135 (23): 2033–40.
• 8. Becker, R.C. (2020). COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis, 15: 1–14.